 |
|
  |
        |
 |
|
|
|||||
|
 Design of recombinant proteins with desired  properties
initially became possible in 1982 with the publishing of the first mutagenesis
studies. In these past twenty years, however, successful examples of protein
engineering have been rare. Our technology represents the first successful
design of super active analogs of glycoprotein hormones that shows major
increases in bioactivity and far exceeds results shown for other protein
ligands. |
|
